Mobile App-assisted Behavioral Treatment in Children and Adolescents With Tics

Sponsor
Aarhus University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05390268
Collaborator
(none)
60
1
2
44.1
1.4

Study Details

Study Description

Brief Summary

Chronic tic disorders are neurodevelopmental disorders affecting 0.5-1% of children and adolescents. Tics present as sudden, rapid, repetitive non-rhythmic movements or vocalizations or a combination. Tics may be extremely distressing in a child's life, but the severity of tics is often variable. The group of children/ adolescents with tic disorders are heterogenous when it comes to symptom presentation, comorbid conditions and social status. This places great demands on professionals to offer the right treatment at the right time. The aim of the current project is to make optimal tics training more accessible, including for patients managed in primary care, to make optimal treatment available in the immediate environment, and to ensure increased adherence to treatment.

As part of this project, an app has been developed and the study aims to evaluate mobile app-assisted behavioral treatment as an efficient and feasible approach that may be a valuable tool together with other treatment approaches. The mobile app-assisted training is based on the manual "Niks til Tics", which describes training with a combination of Habit Reversal Training (HRT) and Exposure Response Prevention (ERP) over nine sessions. Both HRT and ERP are known to be effective treatments of tics.

In this project a randomized controlled superiority trial evaluates the effect of app-assisted training versus an educational approach. Participants are randomized to manualised treatment combining HRT and ERP as app-assisted training, or to one session of psychoeducation supplemented with access to videos repeating the information. The participants are included according to the same criteria as in a pilot trial, and primary outcome measure is YGTSS at session 8. Furthermore, the change in tics intensity from baseline to randomization will be included as to evaluate the effect of being admitted and examined at the hospital.

This project contributes to increased knowledge about tics and tic treatment especially treatment using digital based interventions. An app has been developed for this project and the hypothesis is that a mobile app-assisted tic training program requiring minimal hospital contacts is superior to app-based psychoeducation alone, which is the most likely intervention that these patients will be offered.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mobile app-assisted behavioral treatment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
The assessor is not involved in the treatment of the patient
Primary Purpose:
Treatment
Official Title:
Mobile App-assisted Behavioral Treatment (MA-BT) in Children and Adolescents With an Impairing Tic Disorder. Randomized Clinical Trial Evaluating Treatment Response and Satisfaction
Actual Study Start Date :
Apr 30, 2022
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: digital tic training

The active treatment including apps released for every session

Behavioral: Mobile app-assisted behavioral treatment
The app-assisted training group have access to a newly developed app in which they are taught how to handle tics. A new app session is released at each new treatment session and the content of the app videos is comparable to the information and training at face-to-face individual treatment, as defined by the manual "Niks to Tics"[

Active Comparator: digital tic learner

The control arm including apps released in the first session

Behavioral: Mobile app-assisted behavioral treatment
The app-assisted training group have access to a newly developed app in which they are taught how to handle tics. A new app session is released at each new treatment session and the content of the app videos is comparable to the information and training at face-to-face individual treatment, as defined by the manual "Niks to Tics"[

Outcome Measures

Primary Outcome Measures

  1. Change of baseline Yale Global Tic Severity Scale (YGTSS) at 16 weeks, 24 weeks, 40 weeks, 68 weeks [Baseline, 6 weeks, 16 weeks, 24 weeks, 40 weeks, 68 weeks]

    YGTSS - a clinician-administered semi-structured interview including a checklist of all tic symptoms

Secondary Outcome Measures

  1. Change of baseline premonitory urge scale (PUTS) [Baseline, 6 weeks, 16 weeks, 24 weeks, 40 weeks, 68 weeks]

    PUTS is a short self-reporting scale with nine items

  2. Change of baseline beliefs about tics scale (BATS) [Baseline, 6 weeks, 16 weeks, 24 weeks, 40 weeks, 68 weeks]

    BATS is a self-reporting scale with 20 items

  3. Change of baseline parent and child self-evaluating questionnaire [Baseline, 16 weeks, 24 weeks, 40 weeks, 68 weeks]

    Based on PTQ - a parent evaluating questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
9 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • a primary diagnosis of either Tourette syndrome, chronic motor/vocal tics disorder or severe transient tics according to the WHO ICD-10 diagnostic criteria and Statistical Manual of Mental Disorders

  • a total score higher than 13 on the Yale Global Tic Severity Scale (YGTSS)

Exclusion Criteria:
  • psychotic disorder

  • primary severe depression

  • suicidal ideation or attempts

  • primary severe eating disorder

  • IQ below 70 (mental retardation)

  • participation in tic training based on HRT/ERP treatment within 6 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 AarhusUH Aarhus N Risskov Denmark 8240

Sponsors and Collaborators

  • Aarhus University Hospital

Investigators

  • Study Chair: Per Thomsen, Phd, Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Psychiatry, Aarhus, Denmark

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Judith Becker Nissen, associate professor, phd, senior doctor, Aarhus University Hospital
ClinicalTrials.gov Identifier:
NCT05390268
Other Study ID Numbers:
  • 1-16-02-355-21
First Posted:
May 25, 2022
Last Update Posted:
May 25, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Judith Becker Nissen, associate professor, phd, senior doctor, Aarhus University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 25, 2022